Hepion Pharmaceuticals logo

Hepion Pharmaceuticals share price today

(HEPA)

Hepion Pharmaceuticals share price is $0.65 & ₹55.78 as on 7 Jan 2025, 2.30 'hrs' IST

$0.65

0.02

(2.7%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Hepion Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Hepion Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Hepion Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Hepion Pharmaceuticals share price movements

  • Today's Low: $0.62
    Today's High: $0.71

    Day's Volatility :12.68%

  • 52 Weeks Low: $0.43
    52 Weeks High: $3.49

    52 Weeks Volatility :87.67%

Hepion Pharmaceuticals Returns

PeriodHepion Pharmaceuticals IncIndex (Russel 2000)
3 Months
2.29%
0.0%
6 Months
-38.75%
0.0%
1 Year
-79.52%
0.0%
3 Years
-97.41%
-19.8%

Hepion Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$0.637
Open
$0.7
Today's High
$0.71
Today's Low
$0.62
Market Capitalization
$3.3M
Today's Volume
$476.2K
52 Week High
$3.4899
52 Week Low
$0.4303
Revenue TTM
$0.0
EBITDA
$-31.5M
Earnings Per Share (EPS)
$-4.4
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-189.52%

How to invest in Hepion Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Hepion Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Hepion Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Hepion Pharmaceuticals or HEPA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Hepion Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Hepion Pharmaceuticals shares which would translate to 1.320 fractional shares of Hepion Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Hepion Pharmaceuticals, in just a few clicks!

Returns in Hepion Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Hepion Pharmaceuticals investment value today

Current value as on today

₹24,123

Returns

₹75,877

(-75.88%)

Returns from Hepion Pharmaceuticals Stock

₹79,100 (-79.1%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Hepion Pharmaceuticals

113%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Hepion Pharmaceuticals on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 113% more investors are searching Hepion Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Hepion Pharmaceuticals

  • Anson Funds Management LP

    3.33%

  • Vanguard Group Inc

    1.31%

  • BlackRock Inc

    1.19%

  • Geode Capital Management, LLC

    0.68%

  • Citadel Advisors Llc

    0.42%

  • Renaissance Technologies Corp

    0.24%

Analyst Recommendation on Hepion Pharmaceuticals

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Hepion Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Hepion Pharmaceuticals

What analysts predicted

Upside of 4515.38%

Current:

$0.65

Target:

$30.00

Insights on Hepion Pharmaceuticals

  • Price Movement

    In the last 7 days, HEPA stock has moved up by 48.0%
  • HEPA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 100.5%
  • HEPA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 152.6%

Hepion Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Hepion Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Hepion Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Hepion Pharmaceuticals Inc
5.29%
-38.75%
-79.52%
-97.41%
-99.43%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Hepion Pharmaceuticals Inc
NA
NA
NA
0.0
-1.9
-0.93
NA
1.16
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Hepion Pharmaceuticals Inc
Buy
$3.3M
-99.43%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Hepion Pharmaceuticals

hepion pharmaceuticals, inc., a biopharmaceutical company, focuses on the development of pleiotropic drug therapy for the treatment of chronic liver diseases in the united states. it is involved in developing crv431, a cyclophilin inhibitor that has completed the phase i clinical trials for multiple biochemical pathways involved in the progression of liver diseases; and tenofovir exalidex, a lipid acyclic nucleoside phosphonate that delivers high intracellular concentrations of the active antiviral agent tenofovir diphosphate for the treatment of hepatitis b. the company was formerly known as contravir pharmaceuticals, inc. and changed its name to hepion pharmaceuticals, inc. in july 2019. hepion pharmaceuticals, inc. was incorporated in 2013 and is headquartered in edison, new jersey.
Organization
Hepion Pharmaceuticals
Employees
22
CEO
Mr. John Patrick Brancaccio CPA
Industry
Health Technology

Management People of Hepion Pharmaceuticals

NameTitle
Mr. John Patrick Brancaccio CPA
Interim CEO, Interim CFO & Chairman of the Board
Sharen Pyatetskaya
Director of Investor Relations

Important FAQs about investing in Hepion Pharmaceuticals from India :

What is Hepion Pharmaceuticals share price today?

Hepion Pharmaceuticals share price today stands at $0.65, Open: $0.70 ; Previous Close: $0.64 ; High: $0.71 ; Low: $0.62 ; 52 Week High: $3.49 ; 52 Week Low: $0.43. The stock opens at $0.70, after a previous close of $0.64. The stock reached a daily high of $0.71 and a low of $0.62, with a 52-week high of $3.49 and a 52-week low of $0.43.

Can Indians buy Hepion Pharmaceuticals shares?

Yes, Indians can invest in the Hepion Pharmaceuticals (HEPA) from India.

With INDmoney, you can buy Hepion Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Hepion Pharmaceuticals at zero transaction cost.

How can I buy Hepion Pharmaceuticals shares from India?

It is very easy to buy Hepion Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Hepion Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Hepion Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Hepion Pharmaceuticals stocks?

To start investing in Hepion Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Hepion Pharmaceuticals

Today’s highest price of Hepion Pharmaceuticals (HEPA) is $0.71.

Today’s lowest price of Hepion Pharmaceuticals (HEPA) is $0.62.

What is today's market capitalisation of Hepion Pharmaceuticals

Today's market capitalisation of Hepion Pharmaceuticals HEPA is 3.3M

What is the 52 Week High and Low Range of Hepion Pharmaceuticals

  • 52 Week High

    $3.49

  • 52 Week Low

    $0.43

What are the historical returns of Hepion Pharmaceuticals?

  • 1 Month Returns

    5.29%

  • 3 Months Returns

    -38.75%

  • 1 Year Returns

    -79.52%

  • 5 Years Returns

    -99.43%

Who is the Chief Executive Officer (CEO) of Hepion Pharmaceuticals

Mr. John Patrick Brancaccio CPA is the current Chief Executive Officer (CEO) of Hepion Pharmaceuticals.